CXCR inhibitor SB265610, Purity ≥98%

Synonym: 211096-49-0; SB-265610; SB 265610; N-(2-BROMOPHENYL)-N'-(7-CYANO-1H-BENZOTRIAZOL-4-YL)UREA; sb265610; CHEMBL38182; 1-(2-Bromophenyl)-3-(7-cyano-2H-benzotriazol-4-yl)urea; CXCR inhibitor

CAS Number: 211096-49-0
Compound CID: 9841667

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

SB265610 targets the chemokine receptors CXCR, which are part of the GPCR family. It targets CXCR2.

Molecular Weight

357.16

Molecular Formula

C₁₄H₉BrN₆O

Targets

CXCR2

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

SB265610 can be applied in studies focusing on its role as a selective CXCR2 antagonist in inflammatory processes.

Storage

Store at -20ºC.